XML 32 R21.htm IDEA: XBRL DOCUMENT v3.6.0.2
Fair Value Measurements (Tables)
6 Months Ended
Nov. 30, 2016
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables present information about the Company’s financial assets measured at fair value on a recurring basis as of November 30, 2016 and May 31, 2016, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement.
 
 
As of November 30, 2016
(In millions)
 
Assets at Fair Value
 
Cash and Equivalents
 
Short-term Investments
 
Other Long-term Assets
Cash
 
$
681

 
$
681

 
$

 
$

Level 1:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
1,256

 
350

 
906

 

Level 2:
 
 
 
 
 
 
 
 
Time deposits
 
820

 
781

 
39

 

U.S. Agency securities
 
628

 
335

 
293

 

Commercial paper and bonds
 
647

 
281

 
366

 

Money market funds
 
1,911

 
1,911

 

 

Total Level 2:
 
4,006

 
3,308

 
698

 

Level 3:
 
 
 
 
 
 
 
 
Non-marketable preferred stock
 
10

 

 

 
10

TOTAL
 
$
5,953

 
$
4,339

 
$
1,604

 
$
10


 
 
As of May 31, 2016
(In millions)
 
Assets at Fair Value
 
Cash and Equivalents
 
Short-term Investments
 
Other Long-term Assets
Cash
 
$
774

 
$
774

 
$

 
$

Level 1:
 
 
 
 
 
 
 
 
U.S. Treasury securities
 
1,265

 
100

 
1,165

 

Level 2:
 
 
 
 
 
 
 
 
Time deposits
 
831

 
827

 
4

 

U.S. Agency securities
 
679

 

 
679

 

Commercial paper and bonds
 
733

 
262

 
471

 

Money market funds
 
1,175

 
1,175

 

 

Total Level 2:
 
3,418

 
2,264

 
1,154

 

Level 3:
 
 
 
 
 
 
 
 
Non-marketable preferred stock
 
10

 

 

 
10

TOTAL
 
$
5,467

 
$
3,138

 
$
2,319

 
$
10

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
The following tables present information about the Company’s derivative assets and liabilities measured at fair value on a recurring basis as of November 30, 2016 and May 31, 2016, and indicate the level in the fair value hierarchy in which the Company classifies the fair value measurement.
 
 
As of November 30, 2016
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Assets at Fair Value
 
Other Current Assets
 
Other Long-term Assets
 
Liabilities at Fair Value
 
Accrued Liabilities
 
Other Long-term Liabilities
Level 2:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options(1)
 
$
844

 
$
657

 
$
187

 
$
92

 
$
86

 
$
6

Embedded derivatives
 
10

 
4

 
6

 
9

 
2

 
7

TOTAL
 
$
854

 
$
661

 
$
193

 
$
101

 
$
88

 
$
13

(1)
If the foreign exchange derivative instruments had been netted on the Unaudited Condensed Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $92 million as of November 30, 2016. As of that date, the Company had received $369 million of cash collateral from various counterparties related to these foreign exchange derivative instruments. No amount of collateral was posted on the Company's derivative liability balance as of November 30, 2016.

 
 
As of May 31, 2016
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Assets at Fair Value
 
Other Current Assets
 
Other Long-term Assets
 
Liabilities at Fair Value
 
Accrued Liabilities
 
Other Long-term Liabilities
Level 2:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options(1)
 
$
603

 
$
487

 
$
116

 
$
145

 
$
115

 
$
30

Embedded derivatives
 
7

 
2

 
5

 
9

 
2

 
7

Interest rate swaps(2)
 
7

 
7

 

 
45

 
45

 

TOTAL
 
$
617

 
$
496

 
$
121

 
$
199

 
$
162

 
$
37

(1)
If the foreign exchange derivative instruments had been netted on the Condensed Consolidated Balance Sheets, the asset and liability positions each would have been reduced by $136 million as of May 31, 2016. As of that date, the Company had received $105 million of cash collateral from various counterparties related to these foreign exchange derivative instruments. No amount of collateral was posted on the Company’s derivative liability balance as of May 31, 2016.
(2)
As of May 31, 2016, no amount of cash collateral had been received or posted on the derivative asset or liability balance related to the Company's interest rate swaps.
The following table presents the fair values of derivative instruments included within the Unaudited Condensed Consolidated Balance Sheets as of November 30, 2016 and May 31, 2016: 
 
 
Derivative Assets
 
Derivative Liabilities
(In millions)
 
Balance Sheet
Location
 
November 30,
2016
 
May 31,
2016
 
Balance Sheet 
Location
 
November 30,
2016
 
May 31,
2016
Derivatives formally designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options
 
Prepaid expenses and other current assets
 
$
490

 
$
447

 
Accrued liabilities
 
$
26

 
$
38

Interest rate swaps
 
Prepaid expenses and other current assets
 

 
7

 
Accrued liabilities
 

 
45

Foreign exchange forwards and options
 
Deferred income taxes and other assets
 
165

 
90

 
Deferred income taxes and other liabilities
 
3

 
12

Total derivatives formally designated as hedging instruments
 
 
 
655

 
544

 
 
 
29

 
95

Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards and options
 
Prepaid expenses and other current assets
 
167

 
40

 
Accrued liabilities
 
60

 
76

Embedded derivatives
 
Prepaid expenses and other current assets
 
4

 
2

 
Accrued liabilities
 
2

 
2

Foreign exchange forwards and options
 
Deferred income taxes and other assets
 
22

 
26

 
Deferred income taxes and other liabilities
 
3

 
19

Embedded derivatives
 
Deferred income taxes and other assets
 
6

 
5

 
Deferred income taxes and other liabilities
 
7

 
7

Total derivatives not designated as hedging instruments
 
 
 
199

 
73

 
 
 
72

 
104

TOTAL DERIVATIVES
 
 
 
$
854

 
$
617

 
 
 
$
101

 
$
199